Related Experiment Video
Updated: May 22, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats
Su-Ching Yang1, Hsin-Yi Yang, Yi-Ching Yang
1School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan.
Insights
Chlorella pyrenoidosa supplementation effectively lowered blood pressure and protected against cardiorenal damage in hypertensive rats. This natural intervention may offer a therapeutic strategy for cardiovascular health by inhibiting ACE activity.
Area of Science:
- Cardiovascular Science
- Nutritional Science
- Pharmacology
Background:
- Hypertension is a primary risk factor for cardiovascular diseases.
- Endothelial dysfunction, induced by N (ω)-nitro-L-arginine methyl ester hydrochloride (L-NAME), serves as a model for studying hypertension.
- Cardiorenal remodeling is a significant pathological consequence of sustained hypertension.
Purpose of the Study:
- To evaluate the impact of Chlorella pyrenoidosa on blood pressure in L-NAME-induced hypertensive rats.
- To assess the effects of Chlorella pyrenoidosa on cardiorenal remodeling.
- To explore potential mechanisms underlying Chlorella pyrenoidosa's effects, including ACE inhibition.
Main Methods:
- Rats were administered L-NAME (40 mg/kg) with or without Chlorella pyrenoidosa (4% or 8%) in their diet for 5 weeks.
- Blood pressure and cardiorenal parameters were monitored throughout the experimental period.
- Plasma and tissue samples were analyzed for ACE activity, nitric oxide metabolites, arginine, tumor necrosis factor-α, and CYP4A expression.
Main Results:
- Chlorella pyrenoidosa supplementation significantly attenuated the development of hypertension and cardiorenal remodeling.
- ACE activity in plasma and tissues was notably reduced in rats treated with Chlorella pyrenoidosa.
- Levels of tumor necrosis factor-α and renal CYP4A expression were decreased in the Chlorella pyrenoidosa groups.
Conclusions:
- Chlorella pyrenoidosa demonstrates cardiorenal protective effects in a rat model of nitric oxide deficiency.
- The antihypertensive and cardiorenal protective effects of Chlorella pyrenoidosa may be attributed to its angiotensin-converting enzyme (ACE) inhibitory activity.
- These findings suggest Chlorella pyrenoidosa as a potential therapeutic agent for managing hypertension and related cardiovascular complications.
Purpose:
Hypertension is one of the main factors causing cardiovascular diseases. The aim of the study is to investigate the effects of Chlorella pyrenoidosa on blood pressure and cardiorenal remodeling in rats with N (ω)-nitro-L-arginine methyl ester hydrochloride (L-NAME)-induced endothelial dysfunction.
Methods:
Rats were fed a diet containing L-NAME (40 mg/kg) with or without chlorella (4 or 8 %) for 5 weeks. We found that chlorella retarded the development of hypertension and cardiorenal remodeling during the 5-week experimental period.
Results:
Although there was no difference in NO( x ) levels or plasma arginine concentrations, plasma and tissues ACE activities were significantly lower in the chlorella groups than in the L-NAME group. Moreover, tissue tumor necrosis factor-α concentrations and renal CYP4A expression were also lower in the chlorella group.
Conclusion:
These results suggest that chlorella might ameliorate the elevation of blood pressure and show cardiorenal-protective effects in nitric oxide-deficient rats, and one possible mechanism might be mediated by its ACE inhibitory activity.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Cardiomyopathy V: Interprofessional Care
Antihypertensive Drugs: Direct Renin Inhibitors

